Resistance to antimicrobial drugs, that is, the natural process by which microorganisms (bacteria, viruses, parasites and fungi) develop resistance to the drugs that are used to treat them, is an issue that increasingly threatens to put our capacity at risk to treat infectious diseases and the progress made in global health in recent decades.
The research lines that are developed are encompassed in four major areas:
- Knowledge of the molecular bases of microbial resistance, basically in multiresistant Gram-negative bacilli, Mycobacterium spp. and cytomegalovirus.
- Development of rapid diagnostic tools based on mass spectrometry techniques, molecular biology fundamentally massive sequencing methods.
- Design of new antimicrobial agents. We have two patents.
- Fecal microbiota transplantation and antimicrobial resistance